Castegna, A. ., Lauderback, C. ., Mohmmad-Abdul, H. ., & Butterfield, D. . (2004). Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer’s disease. Brain Research, 1004(1-2), 193-7. https://doi.org/10.1016/j.brainres.2004.01.036 (Original work published 2004)

Lauderback, C. ., Drake, J. ., Zhou, D. ., Hackett, J. ., Castegna, A. ., Kanski, J. ., … Butterfield, D. . (2003). Derivatives of xanthic acid are novel antioxidants: application to synaptosomes. Free Radical Research, 37(4), 355-65. https://doi.org/10.1080/1071576021000040664

Butterfield, D. ., Castegna, A. ., Lauderback, C. ., & Drake, J. . (1969). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiology of Aging, 23(5), 655-64. https://doi.org/10.1016/s0197-4580(01)00340-2 (Original work published 1969)

Butterfield, D. ., & Lauderback, C. . (2002). Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biology & Medicine, 32(11), 1050-60. https://doi.org/10.1016/s0891-5849(02)00794-3 (Original work published 2002)

Lauderback, C. ., Kanski, J. ., Hackett, J. ., Maeda, N. ., Kindy, M. ., & Butterfield, D. . (2002). Apolipoprotein E modulates Alzheimer’s Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Research, 924(1), 90-7. https://doi.org/10.1016/s0006-8993(01)03228-0 (Original work published 2002)

Lauderback, C. ., Hackett, J. ., Huang, F. ., Keller, J. ., Szweda, L. ., Markesbery, W. ., & Butterfield, D. . (2001). The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer’s disease brain: the role of Abeta1-42. Journal of Neurochemistry, 78(2), 413-6. https://doi.org/10.1046/j.1471-4159.2001.00451.x

Zhou, D. ., Lauderback, C. ., Yu, T. ., Brown, S. ., Butterfield, D. ., & Thompson, J. . (2001). D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. The Journal of Pharmacology and Experimental Therapeutics, 298(1), 103-9. Retrieved from https://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=11408530

Pocernich, C. ., Cardin, A. ., Racine, C. ., Lauderback, C. ., & Butterfield, D. . (2001). Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochemistry International, 39(2), 141-9. https://doi.org/10.1016/s0197-0186(01)00012-2

Lauderback, C. ., Hackett, J. ., Keller, J. ., Varadarajan, S. ., Szweda, L. ., Kindy, M. ., … Butterfield, D. . (2001). Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer’s disease. Biochemistry, 40(8), 2548-54. https://doi.org/10.1021/bi002312k (Original work published 2001)

Lauderback, C. ., Breier, A. ., Hackett, J. ., Varadarajan, S. ., Goodlett-Mercer, J. ., & Butterfield, D. . (2000). The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes. Biochimica Et Biophysica Acta, 1501(2-3), 149-61. https://doi.org/10.1016/s0925-4439(00)00015-6 (Original work published 2000)